at DraperFree - $35
To boost U.S. technological innovation and commercialization, our federal government has invested tens of billions of dollars in domestic companies since the 1970s through its Small Business Innovation Research (SBIR) grants program. Administered by the Small Business Administration (SBA), and managed through 11 federal agencies, including the Department of Defense, the Department of Health and Human Services and the National Science Foundation, the program provides funding and support to hundreds of grant awardee companies per year. These SBIR programs annually provide $2.5 billion in non-dilutive funding to small advanced technology firms represent America’s Largest Seed Fund.
SBIR exists “to provide funding for some of the best early-stage innovation ideas — ideas that, however promising, are still too high risk for private investors, including venture capital firms.”
– Roland Tibbetts, Founder of the SBIR program
Join us for our first annual SBIR lunch event. At this lunch-and-learn, a panel of successful grant awardees will deconstruct the application process and the major challenges and roadblocks, as well as speak to what this non-dilutive funding means to them, their companies, and their investors. Learn from their successes and mistakes; hear concrete advice about what really helped their application stand out from the rest.
Grant writing requirements for SBIR/STTR can make the process seem daunting, but, as with other types of fundraising, there are negatives and positives to this financial resource. Given the validation and non-dilutive nature of this source, it can be well worth the effort. At the end of this lunch, you will be empowered to find the right opportunity for you and your company, know where to go to get the help you need, and take the first steps to being a successful grant awardee!
Founder of The Isis Editing Group
The Isis Group is a scientific consulting and communications company. We assist entrepreneurs in the scientific and business aspects of starting biotech companies, and also provide assistance to scientists in the technical writing and editing of scientific and medical communications, including SBIR/STTR and other NIH grants. We have helped biotech startups developing therapeutics, diagnostics, medical devices or healthcare IT solutions obtain millions of dollars in non-dilutive funding through the SBIR/STTR program and other granting mechanisms from the NIH, NSF, USDA and DoD as well as private foundations.
Founder & CEO of CueThink
Sheela Sethuraman has 20 years of experience in building and implementing educational technology solutions in K-12 classrooms. At CueThink, Sheela and her team have successfully taken the vision of a peer platform for math problem solving and built and deployed a scalable application to foster critical thinking and collaboration skills. As Founder and CEO, Sheela has been instrumental in securing SBIR $1.5MM from National Science Foundation and NewSchools Venture Fund, fostering partnerships with leading Math groups and selling to school districts across the country. Prior to CueThink, Sheela was Project Director at Pearson Education, focusing on technologically innovative assessment items based on Common Core State Standards. Before that, Sheela was Director of Technology at CAST, where she spearheaded numerous technical products including CAST eReader and Thinking Reader. Sethuraman has been a member of various consortiums such as Web Access Initiative (WAI), National Instructional Materials Accessibility Standard (NIMAS) and Open eBook Forum. She has also been a podcaster for the Stanford Business School’s Center for Social Innovation.
Founder and Chief Operating Officer, Energesis PharmaceuticalsDr. Freeman is an entrepreneur and physician who is President and Co-Founder of Energesis Pharmaceuticals, a company developing therapeutics targeting brown fat for the treatment of obesity and diabetes. He previously served as a Venture Partner at GreatPoint Ventures. He is a founder of Zafgen, a venture-backed company developing new therapeutics for obesity based on a novel approach, and served as the company’s founding Vice President of Business Development. He was formerly an Engagement Manager at MEDACorp (now Leerink Swann Strategic Advisors), where he advised pharmaceutical and biotechnology companies on strategic acquisitions, in-licensing, pipeline prioritization, and clinical development. Previously he worked with the Neuroscience Clinical Development group at Wyeth and in medical diagnostics development at Mitsubishi Pharma. Dr. Freeman performed his clinical training in neurology at the University of Pennsylvania, obtained his medical degree and Masters in Molecular Cell Biology from Washington University in St. Louis, and completed his undergraduate work at MIT.
SBIR Advisor at UMASS Small Business Development Center
Dan is the SBIR and Government Sales Advisor to the Massachusetts Business community at the University of Massachusetts Small Business Development Center. He is responsible for designing and implementing a successful statewide SBIR advisory program. Serving as Government Sales Advisor to Southeastern Massachusetts businesses with a primary focus on defense contracts. Dan mentors and reviews countless SBIR applications a year!
Co-Founder, Resilience Therapeutics
Retsina Meyer has been working in neuroscience for over a decade producing over 40 articles, abstracts, and lectures. Her recent discoveries have gained international press and earned her a speaking engagement at the local TEDx conference. As an entrepreneur, Dr. Meyer is an alumna of MassBIO’s MassCONNECT program and SpringBoard’s Life Sciences Accelerator. She went on to advance Resilience through the OneStart America’s competition awarded by GSK’s SR One and Oxbridge Biotech Roundtable, emerging as the winner of the #1 emerging life science company.
Dr. Meyer obtained a Neuroscience Ph.D. at MIT where she earned 5 named fellowships and was a Presidential Fellow, Imperial College of London Global Fellow, and a Graduate Woman of Excellence. While in academia, Retsina served as a science advocate with the Science Policy Initiative, attained over a million dollars in grants, fellowships, and awards during her academic career, consulted for local startups, and mentored numerous scientists from undergraduate to post doctoral level.
Thanks to our location sponsor
Please note that TCN events are open to entrepreneurs and investors only, or approved guests of TCN. Service providers of any type must join TCN as a Sponsor. Email firstname.lastname@example.org for details.
Join as a member Want unlimited access to everything The Capital Network has to offer?
Join as a member for access to events and more.
Join as a member
Want unlimited access to everything The Capital Network has to offer?